Rationale and timing of perioperative chemotherapy for upper-tract urothelial carcinoma

Keyphrases

• Upper Tract Urothelial Carcinoma 100%
• Preoperative Chemotherapy 100%
• Cancer Control 33%
• High Risk 33%
• Bladder Cancer 33%
• Combined Modality Therapy 33%
• Surgery Alone 33%
• Patient's Will 33%
• Metastatic Disease 33%
• Adjuvant Chemotherapy 33%
• Cancer Outcomes 33%
• Disease-specific Survival 33%
• Optimal Timing 33%
• Additional Therapy 33%
• Standard of Care 33%
• Lack of Consensus 33%
• Neoadjuvant Chemotherapy 33%
• Radical Surgery 33%
• Cancer Disease 33%

Medicine and Dentistry

• Transitional Cell Carcinoma 100%
• Malignant Neoplasm 33%
• Cancer Control 33%
• Metastatic Carcinoma 33%
• Bladder Cancer 33%
• Adjuvant Chemotherapy 33%
• Disease Specific Survival 33%
• Neoadjuvant Chemotherapy 33%
• Radical Surgery 33%